Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Merck
McKinsey
AstraZeneca
Boehringer Ingelheim

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Merck & Co., Inc. v. Universal Drug Store Ltd. (S.D.N.Y. 2005)

See Plans and Pricing

« Back to Dashboard

Merck & Co., Inc. v. Universal Drug Store Ltd. (S.D.N.Y. 2005)

Docket   Start Trial Date Filed 2005-04-11
Court District Court, S.D. New York Date Terminated 2006-10-27
Cause 28:1331 Fed. Question: Other Assigned To Denny Chin
Jury Demand Defendant Referred To Magistrate Judge Gabriel W. Go
Parties MERCK & CO., INC.; MSD TECHOLOGY L.P.; UNIVERSAL DRUG STORE LTD.
Patents 4,444,784
Attorneys Ilaria Maggioni; John DeQ. Briggs; Kenneth Wade Donnelly; Nina . Shreve; Peter DeForest Shapiro
Firms Fitzpatrick, Cella, Harper & Scinto
Link to Docket External link to docket
Small Molecule Drugs cited in Merck & Co., Inc. v. Universal Drug Store Ltd.
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Merck & Co., Inc. v. Universal Drug Store Ltd. (S.D.N.Y. 2005)

Date Filed Document No. Description Snippet Link To Document
2005-04-11 1 ) infringement of United States Patent No. 4,444,784 (“the ‘784 patent”) under 35 U.S.C. § 271; (b) trademark….C. §§ 139 l (d) and 1400. Merck’s Patent ll. The ‘784 patent, entitled "Antihypercholesterolemic… by the ‘784 patent and has continued to willfully and deliberately infringe that patent. 34. The actions…infringement of the ‘784 patent; C. A judgment finding that Defendant’s patent infringement has been Willful…Defendant has committed tortious and wrongful acts of patent and trademark infringement and dilution, unfair External link to document
2006-03-30 19 ) is the assignee of U.S. Patent No. 4,444,784 ("the '784 patent") for "Antihypercholesterolemic…been the exclusive entity legally authorized by patent laws and the U.S. Food and Drug Administration…2005. Against RxNorth, Merck asserts claims for patent infringement (Count I), unfair competition under… Merck asserts eight counts: federal claims of patent infringement (Count I), trademark infringement…6). No defendant has moved to dismiss the patent infringement claims and those claims are not before External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
McKesson
Medtronic
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.